insights_auto
Why is 4536 down ၃.၁၇%?
Dive Deeperchevron_right
4536:TYO
Santen Pharmaceutical Co Ltd
၁,၇၁၀.၀၀ JP¥
arrow_downward
-၃.၁၇%(-၅၆.၀၀) 1D
စက် ၁၈, GMT+၉ ၁၅:၃၀:၀၀ · JPY
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for 4536...
Open
၁,၇၆၁ JP¥
High
၁,၇၇၀ JP¥
Low
၁,၇၁၀ JP¥
Mkt. cap
ဋေ ၅.၅၁ သ
Avg. vol.
၁.၁၉ သန်း
Volume
၄.၁၅ သန်း
Dividend
၂.၂၂%
Quarterly dividend
၁၀ JP¥
Ex-dividend date
၂၀၂၆ စက် ၂၉
P/E ratio
၁၄.၂၇
52-wk high
၂,၂၅၄ JP¥
52-wk low
၁,၄၅၈ JP¥
EPS
၁၂၀ JP¥
Shares outstanding
၄၀.၇၁ ကုဋေ
No. of employees
၄ ထောင်
Open
၁,၇၆၁ JP¥
High
၁,၇၇၀ JP¥
Low
၁,၇၁၀ JP¥
Mkt. cap
ဋေ ၅.၅၁ သ
Avg. vol.
၁.၁၉ သန်း
Volume
၄.၁၅ သန်း
Dividend
၂.၂၂%
Quarterly dividend
၁၀ JP¥
Ex-dividend date
၂၀၂၆ စက် ၂၉
P/E ratio
၁၄.၂၇
52-wk high
၂,၂၅၄ JP¥
52-wk low
၁,၄၅၈ JP¥
EPS
၁၂၀ JP¥
Shares outstanding
၄၀.၇၁ ကုဋေ
No. of employees
၄ ထောင်
Profile
Santen Pharmaceutical Co., Ltd., is a Japanese pharmaceutical company, specializing in ophthalmology. With its ophthalmic products Santen holds the top share within the Japanese market and is one of the leading ophthalmic companies worldwide, with its products being sold in over 50 countries.
The company was founded in 1890 by Kenkichi Taguchi, as Taguchi Santendo, and in 1925, Santendo Co., Ltd. was established. In 2014 Santen announced that it has entered into an agreement with Merck & Co. to purchase Merck's ophthalmology products. Wikipedia
About Santen Pharmaceutical Co Ltd
CEOAkira Kurokawa | Shigeo Taniuchi
Employees၃.၉၇ ထောင်
Founded၁၈၉၀
Headquartersအိုဆာကာမြို့, Kansai, ဂျပန်
Sector-
Websitesanten.com